These three mechanisms are non-mutually exclusive and suggest that ignoring RNA-mediated pathogenic pathways in HD risks missing opportunities to develop novel therapies that will complement efforts aimed at reducing HTT protein-mediated neurotoxicity. The gene discussed is HTT; the disease is Huntington disease.